Finland· FI-REL-REL758
Locasalen
A flumetasone product containing flumetasone pivalate + salicylic acid, registered in Finland by Novartis Finland Oy. The same ATC class is registered in 4 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Flumetasone is registered in 4 of 19 countries.
Countries holding a registration under ATC D07XB01 (flumetasone), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 3 of them publish a price we can compare per daily dose
Flumetasone · ATC D07XB01
4 / 19 countries
- Belgiumprice
- Finlandprice
- Netherlands
- Polandprice
The record
At a glance
Fimea (Finland)- Active substance
- Flumetasone pivalate + Salicylic acid
- Manufacturer
- Novartis Finland Oy
- Country
- Finland (FI)
- ATC code
- D07XB01
- ATC class
- Flumetasone
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Flumetasone in 2 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- GermanyKeratoson Comp.Infectopharm Arzneimittel Und Consilium Gmbh, De, Heppenheim
- PolandLorinden ABausch Health Ireland Ltd.
Authorised across Europe · EMA
The same active substance is authorised in 8 EEA countries. Names it is sold under:
- Bulgaria · Лоринден A
- Germany · Keratoson Comp., Keratoson Comp. Lösung
- Hungary · Lorinden A
- Italy · Losalen
- Lithuania · Lorinden A
- Latvia · Lorinden A
- Netherlands · Locasalen
- Poland · Lorinden A
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bc7e74f0-e577-4bc3-877a-76d5e216fe69 GET /v1/drugs/bc7e74f0-e577-4bc3-877a-76d5e216fe69?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": null,
"form": "voide",
"route": null,
"ddd_unit": null,
"strength": null,
"atc_label": "flumetasoni",
"ma_number": "6029",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL758",
"authorised_at": "1970-04-22"
}See everything about flumetasone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.